Samuel Philip Rowbotham, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hedgehog Proteins | 1 | 2022 | 774 | 0.600 |
Why?
|
Histone Demethylases | 1 | 2018 | 311 | 0.550 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2020 | 1674 | 0.410 |
Why?
|
Lung Neoplasms | 5 | 2022 | 12985 | 0.410 |
Why?
|
Chromatin | 4 | 2023 | 2848 | 0.390 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3614 | 0.380 |
Why?
|
DNA Helicases | 3 | 2015 | 843 | 0.370 |
Why?
|
Lung | 4 | 2023 | 9782 | 0.330 |
Why?
|
Cell Lineage | 1 | 2017 | 2486 | 0.320 |
Why?
|
DNA Replication | 2 | 2011 | 1389 | 0.300 |
Why?
|
Methylation | 2 | 2023 | 1106 | 0.270 |
Why?
|
Stem Cells | 1 | 2017 | 3566 | 0.230 |
Why?
|
Organoids | 2 | 2020 | 687 | 0.230 |
Why?
|
Disease Progression | 1 | 2018 | 13237 | 0.210 |
Why?
|
Histones | 2 | 2011 | 2591 | 0.200 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 666 | 0.190 |
Why?
|
Heterochromatin | 2 | 2011 | 293 | 0.170 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6318 | 0.140 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1991 | 0.130 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2015 | 87 | 0.130 |
Why?
|
Genes, erbB-1 | 1 | 2015 | 161 | 0.120 |
Why?
|
Neoplastic Stem Cells | 1 | 2022 | 1380 | 0.120 |
Why?
|
Acetylation | 2 | 2011 | 1085 | 0.100 |
Why?
|
Animals | 8 | 2023 | 168368 | 0.100 |
Why?
|
Mice | 6 | 2023 | 81002 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2018 | 1734 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 136 | 0.090 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2011 | 283 | 0.090 |
Why?
|
S Phase | 1 | 2011 | 422 | 0.090 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 677 | 0.090 |
Why?
|
Mutation | 1 | 2014 | 29658 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1702 | 0.090 |
Why?
|
Cell Survival | 1 | 2018 | 5877 | 0.080 |
Why?
|
Nucleosomes | 1 | 2011 | 488 | 0.080 |
Why?
|
Adenosine Triphosphatases | 1 | 2011 | 835 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1213 | 0.070 |
Why?
|
Wound Healing | 1 | 2017 | 2768 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2014 | 2440 | 0.060 |
Why?
|
HeLa Cells | 1 | 2011 | 3119 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16646 | 0.060 |
Why?
|
Transcription Factors | 2 | 2015 | 12120 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4743 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5181 | 0.060 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4832 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2910 | 0.060 |
Why?
|
DNA Repair | 1 | 2011 | 2030 | 0.050 |
Why?
|
RNA Interference | 1 | 2011 | 2899 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18003 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2011 | 4174 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5221 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16301 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5830 | 0.040 |
Why?
|
Signal Transduction | 1 | 2022 | 23355 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9375 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5632 | 0.040 |
Why?
|
Cell Line | 1 | 2011 | 15987 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2011 | 19220 | 0.030 |
Why?
|
Anaphase | 1 | 2015 | 120 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 637 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 12049 | 0.030 |
Why?
|
Humans | 7 | 2022 | 739398 | 0.030 |
Why?
|
Acyltransferases | 1 | 2014 | 290 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2015 | 623 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1654 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 626 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 617 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3584 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3562 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2960 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3701 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2022 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 1537 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3433 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9714 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5154 | 0.010 |
Why?
|